Detalhe da pesquisa
1.
The Use of Tissue-on-Chip Technology to Focus the Search for Extracellular Vesicle miRNA Biomarkers in Thyroid Disease.
Int J Mol Sci
; 25(1)2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203243
2.
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.
Nucleic Acids Res
; 43(1): 196-207, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488809
3.
Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system.
Lab Chip
; 23(11): 2664-2682, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191188
4.
The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth.
Cancers (Basel)
; 14(14)2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884550
5.
The Histone Demethylase Enzymes KDM3A and KDM4B Co-Operatively Regulate Chromatin Transactions of the Estrogen Receptor in Breast Cancer.
Cancers (Basel)
; 11(8)2019 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390833
6.
Does radiation-induced c-MYC amplification initiate breast oncogenesis?
Mol Cell Oncol
; 3(1): e1010950, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27308527
7.
Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.
Oncotarget
; 6(32): 32396-409, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26486089